Publication | Open Access
Identification of a New Component of the Agonist Binding Site of the Nicotinic α7 Homooligomeric Receptor
150
Citations
26
References
1995
Year
Agonist Binding SiteTorpedo ReceptorMolecular PharmacologyNew ComponentNicotineMolecular PhysiologyBiochemistryAlpha 7Receptor (Biochemistry)NeuropharmacologyTryptophan 54PharmacologySignal TransductionFunctional SelectivityPhysiologyNeuropeptide ReceptorMedicineDrug DiscoveryNeuropeptides
Tryptophan 54 of the alpha 7 neuronal nicotinic homooligomeric receptor is homologous to gamma-Trp-55 and delta-Trp-57 of non-alpha subunits of Torpedo receptor labeled by d-tubocurarine. This residue was mutated on the alpha 7-V201-5-hydroxytryptamine (5HT)3 homooligomeric chimera, which displays alpha 7 nicotinic pharmacology, and for which both equilibrium binding studies and electrophysiological recordings could be carried out in parallel. Replacement of Trp-54 by a Phe, Ala, or His causes a progressive decrease both in binding affinity and in responses (EC50 or IC50) for acetylcholine, nicotine, and dihydro-beta-erythroidine, without significant modification in alpha-Bgtx binding. Except for Gln-56, comparatively small effects are observed when the other residues of the 52-58 region are mutated into alanine. These data support the participation of Trp-54 to ligand binding, and provide evidence for a new "complementary component" of the alpha 7 nicotinic binding site, distinct from its three-loop "principal component," and homologous to the "non-alpha component" present on gamma and delta subunits.
| Year | Citations | |
|---|---|---|
Page 1
Page 1